Menopause and sexual desire: The role of testosterone

Menopause International

Volumn 16, Issue 4, 2010, Pages 162-168

  Nappi, Rossella E ^a,b   Brambilla, Emanuela ^a,b   Polatti, Franco ^a   Albani, Francesca ^b   Santamaria, Valentina ^b   Tonani, Silvia ^b   Martini, Ellis ^b   Terreno, Erica ^b  

^a Research Centre for Reproductive Medicine

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

androgens; Climacteric; hypoactive sexual desire disorder; sexual function

Indexed keywords

ANDROGEN; ESTROGEN; METHYLTESTOSTERONE; PLACEBO; TESTOSTERONE; TIBOLONE;

ACNE; ALOPECIA; ANDROGEN THERAPY; CLINICAL TRIAL; DRUG MECHANISM; HAIR GROWTH; HUMAN; HYPOACTIVE SEXUAL DESIRE DISORDER; HYPOTHALAMUS; LIMBIC CORTEX; MENOPAUSE; PSYCHOSOCIAL CARE; REVIEW; SEXUAL AROUSAL DISORDER; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SEXUALITY; SIDE EFFECT; VASOMOTOR DISORDER;

ANDROGENS; FEMALE; HUMANS; MENOPAUSE; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TESTOSTERONE;

EID: 78650656572     PISSN: 17540453     EISSN: 17540461     Source Type: Journal    
DOI: 10.1258/mi.2010.010041     Document Type: Review

References (84)

1. World Health Organization. Gender and Reproductive Rights Glossary. 2002. See http://www.who.int/reproductivehealth/en/ (last accessed 26 November 2010)
2. Dennerstein L, Randolph J, Taffe J, Dudley E, Burger H. Hormones, mood, sexuality, and the menopausal transition. Fertil Steril 2002; 77: S42–S48
3. Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000; 96: 351–358
4. Dennerstein L, Dudley E, Burger H. Are changes in sexual functioning during midlife due to aging or menopause? Fertil Steril 2001; 76: 456–60
5. Nappi RE, Nijland EA. Women's perception of sexuality around the menopause: Outcomes of a European telephone survey. Eur J Obstet Gynecol Reprod Biol 2008; 137: 10–16
6. Nappi RE, Baldaro J, Polatti F, Genazzani AR, Zara C. Self-reported sexual symptoms in women attending menopause clinics. J Obstet Gynecol Invest 2002; 53: 181–187
7. Nappi RE, Polatti F. The use of estrogen therapy in women's sexual functioning. J Sex Med 2009; 6: 603–16
8. Lachowsky M, Nappi RE. The effects of oestrogen on urogenital health. Maturitas 2009; 63: 149–51
9. Davis S, Tran J. Testosterone influences libido and well-being in women. Trends Endocrinol Metab 2001; 12: 33–37
10. Nappi RE, Detaddei S, Ferdeghini F, Brundu B, Sommacal A, Polatti F. Role of testosterone in feminine sexuality. J Endocrinol Invest 2003; 26: 97–101
11. Nappi RE, Wawra K, Schmitt S. Hypoactive sexual desire disorder in postmenopausal women. Gynecol Endocrinol 2006; 22: 318–23
12. Nappi RE, Lello S, Melis GB, Albani F, Polatti F, Genazzani AR. LEI (Lack of tEstosterone Impact) survey in a clinical sample with surgical menopause. Climacteric 2009; 12: 533–40
13. Basson R, Berman J, Burnett A,, et al. Report of the International Consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 2000; 163: 888–93
14. Levine SB. The nature of sexual desire: a clinician's perspective. Arch Sexual Behav 2003; 32: 279–85
15. Basson R, Leiblum SL, Brotto L,, et al. Definitions of women's sexual dysfunctions reconsidered: advocating expansion and revision. J Psychosom Obstet Gynecol 2003; 24: 221–229
16. Brotto LA, Bitzer J, Laan E, Leiblum S, Luria M. Women's sexual desire and arousal disorders. J Sex Med 2010; 7: 586–614
17. Meston CM, Frohlich PF. The neurobiology of sexual function. Arch Gen Psychiatry 2000; 57: 1012–30
18. Giraldi A, Marson L, Nappi R,, et al. Physiology of female sexual function: animal models. J Sex Med 2004; 1: 237–53
19. Pfaus JG. Pathways of sexual desire. J Sex Med 2009; 6: 1506–33
20. Nappi R, Salonia A, Traish AM,, et al. Clinical biologic pathophysiologies of women's sexual dysfunction. J Sex Med 2005; 2: 4–25
21. Bancroft J. The endocrinology of sexual arousal. J Endocrinol 2005; 186: 411–27
22. Burger HG. Androgen production in women. Fertil Steril 2002; 77: S3–S5
23. Longcope C. Adrenal and gonadal androgen secretion in normal females. Clin Endocrinol Metab 1986; 15: 213–28
24. Burger HG, Hale GE, Robertson DM, Dennerstein L. A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project. Hum Reprod Update 2007; 13: 559–65
25. Shifren JL, Desindes S, McIlwain M, Doros G, Mazer NA. A randomized, open-label, crossover study comparing the effects of oral versus transdermal estrogen therapy on serum androgens, thyroid hormones, and adrenal hormones in naturally menopausal women. Menopause 2007; 14: 985–94
26. Mushayandebvu T, Castracane VD, Gimpel T, Adel T, Santoro N. Evidence for diminished midcycle ovarian androgen production in older reproductive aged women. Fertil Steril 1996; 65: 721–723
27. Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 2005; 90: 3847–53
28. Zumoff B, Strain GW, Miller LK, Rosner W. Twenty-four hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metab 1995; 80: 1429–30
29. Simon JA. Estrogen replacement therapy: effects on the endogenous androgen milieu. Fertil Steril 2002; 77: S77–S82
30. Zumoff B, Rosenfield RS, Strain GW,, et al. Sex differences in the twenty-four hour mean plasma concentrations of DHA and DHAS and DHA to DHAS ratio in normal adults. J Clin Endocrinol Metab 1995; 51: 330–333
31. Simpson ER. Aromatization of androgens in women: current concepts and findings. Fertil Steril 2002; 77: 6–10
32. Lobo RA. Androgens in postmenopausal women: production, possible role, and replacement options. Obstet Gynecol Surv 2001; 56: 361–76
33. Laughlin GA, Barrett-Connor E, Kritz-Silverstein D, von Muhlen D. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Clin Endocrinol Metab 2000; 85: 645–51
34. Roselli CE, Resko JA. Aromatase activity in the rat brain: hormone regulation and sex differences. J Steroid Biochem Mol Biol 1993; 44: 499–508
35. Frye CA. The role of neurosteroids and non-genomic effects of progestins and androgens in mediating sexual receptivity of rodents. Brain Res Rev 2001; 37: 201–22
36. King SR. Emerging roles for neurosteroids in sexual behavior and function. J Androl 2008; 29: 524–33
37. Labrie F, Luu-The V, Labrie C,, et al. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr Rev 2003; 24: 152–82
38. Alexander JL, Kotz K, Dennerstein L, Kutner SJ, Wallen K, Notelovitz M. The effects of postmenopausal hormone therapies on female sexual functioning: a review of double-blind, randomized controlled trials. Menopause 2004; 11: 749–65
39. Wierman ME, Nappi RE, Avis N,, et al. Endocrine aspects of women's sexual function. J Sex Med 2010; 7: 561–85
40. Davis S, Tran J. Testosterone influences libido and well-being in women. Trends Endocrinol Metab 2001; 12: 33–37
41. Bachmann GA. The hypoandrogenic woman: pathophysiologic overview. Fertil Steril 2002; 77: S72–S76
42. Santoro N, Torrens J, Crawford S,, et al. Correlates of circulating androgens in mid-life women: the study of women's health across the nation. J Clin Endocrinol Metab 2005; 90: 4836–45
43. Davis SR, Davison SL, Donath S, Bell RJ. Circulating androgen levels and self-reported sexual function in women. JAMA 2005; 294: 91–96
44. Salonia A, Pontillo M, Nappi RE,, et al. Menstrual cycle-related changes in circulating androgens in healthy women with self-reported normal sexual function. J Sex Med 2008; 5: 854–63
45. Woods NF, Mitchell ES, Smith-Di K. Sexual desire during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. J Womens Health 2010; 19: 209–18
46. Basson R, Brotto LA, Petkau AJ, Labrie F. Role of androgens in women's sexual dysfunction. Menopause 2010; 17: 962–71
47. Nappi RE, Albani F, Santamaria V,, et al. Hormonal and psycho-relational aspects of sexual function during menopausal transition and at early menopause. Maturitas 2010; 67: 78–83
48. Gallicchio L, Schilling C, Tomic D, Miller SR, Zacur H, Flaws JA. Correlates of sexual functioning among mid-life women. Climacteric 2007; 10: 132–42
49. Avis NE, Zhao X, Johannes CB, Ory M, Brockwell S, Greendale GA. Correlates of sexual function among multi-ethnic middle-aged women: results from the Study of Women's Health Across the Nation (SWAN). Menopause 2005; 12: 385–98
50. Dennerstein L, Lehert P. Women's sexual functioning, lifestyle, mid-age, and menopause in 12 European countries. Menopause 2004; 11: 778–85
51. Nappi RE, Lachowsky M. Menopause and sexuality: prevalence of symptoms and impact on quality of life. Maturitas 2009; 63: 138–41
52. Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol 2008; 112: 970–978
53. Dennerstein L, Koochaki P, Barton I, Graziottin A. Hypoactive sexual desire disorder in menopausal women: a survey of western European women. J Sex Med 2006; 3: 212–22
54. Leiblum S, Koochaki P, Rodenberg C, Barton I, Rosen RC, Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS). Menopause 2006; 13: 46–56
55. Hayes RD, Dennerstein L, Bennett CM, Sidat M, Gurrin LC, Fairley CK. Risk factors for female sexual dysfunction in the general population: exploring factors associated with low sexual function and sexual distress. J Sex Med 2008; 5: 1681–93
56. Rosen RC, Shifren JL, Monz BU, Odom DM, Russo PA, Johannes CB. Correlates of sexually related personal distress in women with low sexual desire. J Sex Med 2009; 6: 1549–60
57. Stephenson KR, Meston CM. Differentiating components of sexual well-being in women: are sexual satisfaction and sexual distress independent constructs? J Sex Med 2010; 7: 2458–68
58. Modelska K, Cummings S. Female sexual dysfunction in postmenopausal women: systematic review of placebo-controlled trials. Am J Obstet Gynecol 2003; 188: 286–93
59. Segraves R, Woodard T. Female hypoactive sexual desire disorder: history and current status. J Sex Med 2006; 3: 408–18
60. Al-Azzawi F, Bitzer J, Brandenburg U,, et al. Therapeutic options for postmenopausal female sexual dysfunction. Climacteric 2010; 13: 103–20
61. Krapf JM, Simon JA. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. Maturitas 2009; 63: 213–219
62. Panzer C, Guay A. Testosterone replacement therapy in naturally and surgically menopausal women. J Sex Med 2009; 68: 8–18
63. Greenblatt RB, Barfield WE, Garner JF, Calk GL, Harrod JP Jr. Evaluation of an estrogen, androgen, estrogen-–androgen combination, and a placebo in the treatment of the menopause. J Clin Endocrinol Metab 1950; 10: 1547–58
64. Schwenkhagen A, Studd J. Role of testosterone in the treatment of hypoactive sexual desire disorder. Maturitas 2009; 63: 152–159
65. Studd J, Panay N. Hormones and depression in women. Climacteric 2004; 7: 338–46
66. Somboonporn W, Davis S, Seif MW, Bell R. Testosterone for peri- and postmenopausal women. Cochrane Database Syst Rev 2005; 4: CD004509
67. Braunstein GD. Safety of testosterone treatment in postmenopausal women. Fertil Steril 2007; 88: 1–17
68. Buster JE, Kingsberg SA, Aguirre O,, et al. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet Gynecol 2005: 105: 944–52
69. Simon J, Braunstein G, Nachtigall L,, et al. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 2005; 90: 5226–33
70. Shifren JL, Braunstein GD, Simon JA,, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000; 343: 682–688
71. Kingsberg S, Shifren J, Wekselman K, Rodenberg C, Koochaki P, Derogatis L. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder. J Sex Med 2007; 4: 1001–8
72. Shifren JL, Davis SR, Moreau M,, et al. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study. Menopause 2006; 13: 770–779
73. Davis SR, Moreau M, Kroll R,, et al. Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med 2008; 359: 2005–17
74. Panay N, Al-Azzawi F, Bouchard C, et al. testosterone treatment of HSDD in naturally menopausal women: the ADORE study. Climacteric 2010; 13: 121–31
75. Goldstat R, Briganti E, Tran J, Wolfe R, Davis SR, Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women. Menopause 2003; 10: 390–398
76. Snabes MC, Simes SM. Approved hormonal treatments for HSDD: an unmet medical need. J Sex Med 2009; 6: 1846–9
77. Braunstein GD. The endocrine society clinical practice guideline and The North American menopause society position statement on androgen therapy in women: another one of Yogi's forks. J Clin Endocrinol Metab 2007; 92: 4091–3
78. NAMS. The role of testosterone therapy in postmenopausal women: position statement of the North American Menopause Society. Menopause 2005; 12: 496–511
79. Wierman ME, Basson R, Davis SR,, et al. Androgen therapy in women: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab 2006; 91: 3697–710
80. de Gooyer ME, Kleyn GT, Smits KC, Ederveen AG, Verheul HA, Kloosterboer HJ. Tibolone: a compound with tissue specific inhibitory effects on sulfatase. Mol Cell Endocrinol 2001; 183: 55–62
81. Biglia N, Maffei S, Lello S, Nappi RE. Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials. Gynecol Endocrinol 2010; 26: 804–14
82. Davis SR. The effects of tibolone on mood and libido. Menopause 2002; 9: 162–70
83. Nijland EA, Weijmar Schultz WC, Nathorst-Boös J,, et al. Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial. J Sex Med 2008; 5: 646–56
84. Labrie F, Archer D, Bouchard C,, et al. High internal consistency and efficacy of intravaginal DHEA for vaginal atrophy. Gynecol Endocrinol 2010; 26: 524–32